Cooperative Agreement U65PS002419

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) is funded through the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). The $4,989,476 award to Community Education Group, Inc. will enable the organization's West Virginia Division (doing business as the National Women & HIV / Aids Project) to provide technical assistance, training, and capacity building support to health departments, community-based...

The Centers for Disease Control and Prevention (CDC) awarded a $4,950,311 Cooperative Agreement under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) to Proceed Inc., doing business as the Puerto Rican Organization for Community Education and Economic Development, from August 2024 to March 2029. The award supports two key components: 1) Project REACH, which aims to enhance the capabilities of community-based organizations (CBOs) and health...

This $836,895 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a 5-year research study to develop and evaluate communication strategies to promote HIV vaccine and prevention uptake among young Black women in the Southern U.S. The project, led by researchers at Baylor College of Medicine, will use community-based participatory methods to co-create theory-based messaging, graphics, and videos to...

The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $7,888,424 Cooperative Agreement under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) to Healthhiv, a national non-profit organization based in Washington, DC. The award supports two key components: 1) eLearning training for high-impact HIV prevention programs, and 2) organization/workforce development and management for community-based...

The San Francisco Department of Public Health's Center for Learning & Innovation was awarded a $4,989,475 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834). Through this 5-year award, the organization will provide tailored technical assistance and capacity building services to health departments, community-based organizations, and other HIV prevention partners...

This federal Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940), aims to strengthen existing agreements and develop new strategies to re-engage people with HIV (PWH) who are not in care and outreach to those who are not virally suppressed in rural communities and municipalities in Puerto Rico. The $1,000,000 award to the Puerto Rico Department of Health (PRDOH) will...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $702,000 to support a 3-year project aimed at optimizing the implementation of long-acting injectable pre-exposure prophylaxis (LAI-PrEP) for HIV prevention. The key objectives are to: 1) Identify barriers and facilitators to LAI-PrEP implementation, 2) Determine optimal implementation strategies in partnership with...

This federal Project Grant award of $1,365,212 from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) aims to optimize and test a peer-led dynamic choice HIV prevention intervention to increase coverage of biomedical prevention products among women at elevated HIV risk in southwestern Uganda. The project will refine the existing Search Dynamic Choice HIV Prevention (DCP) intervention to further engage women working in venues where transactional sex is...

This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to implement an innovative HIV self-testing and long-acting injectable HIV treatment and prevention intervention for commercial minibus drivers in Nigeria. The $809,692 award to The George Washington University, with sub-awards to Wake Forest University Health Sciences, University of Rochester, Emory...

This $100,000 project grant from the Department of State Bureau of East Asian and Pacific Affairs will enable Action Center For People Living With HIV to implement a community-led HIV monitoring program in northern Vietnam from March 2022 through January 2023. The funding supports the U.S. President's Emergency Plan for AIDS Relief Programs (PEPFAR) under the CFDA number 19.029. PEPFAR aims to provide support for HIV/AIDS treatment, care, and prevention activities globally. Under this award,...